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1. Side effects of therapy or chemotherapy 41(36.6%)
2. Procedures (Bone Marrow Aspiration, Hickman Line
insertion etc) 39(34.8%)
3. Infection Control 48(42.8%)
4. Sexuality 9(8%)
5. Fertility 11(9.8%)
6. Results of diagnostic test 59(52.7%)
7. others, blood tests 7(6.2%)
On discharge
1. Outcome of your treatment 65(58%)
2. Follow up, appointment 102(91%)
3. Medication 108(96.4%)
4. What happens next 88(78.5%)
5. When to call the medical team (Hospital) 94(83.9%)
6. Work life 68(60.7%)
7. Other alternative treatment regimens 8(7.1 %)
Total 112 (100%)
Findings & Interpretation: 112 malignant haematology
patients were admitted to our unit for various reasons Our
audit was evaluated in three different stages. The admission
stage; most of the information provided regarded side effects
of treatment and test results (See Table I). Our audit has
shown that, the admission stage was the lowest in terms of
information providing. It should be kept in mind that the
haematology patient group generally has a long hospital-
isation, the data collection tool was given on discharge.
Therefore, it was interpreted that data might be lost due to
poor recall of the information required. We are now giving
the data collection tool on admission rather than on
discharge in an effort to address this matter. Result showed
that Sexuality (9.8%) and fertility (11.6%) were the least
addressed topics; where as results of diagnostic test (43.7%)
was deemed the most important. On the other hand results
also showed our patient were happy about the information
they were given especially on discharge, as most aspects of
information was covered.
Discussion & Implications: For the haematology patient
group, knowing their diseases and potential outcomes does
help in the difﬁcult decision making process of their treat-
ment. Therefore as healthcare professionals it is our duty of
care to provide the information they need, but how far do we
need to go? This study was aimed at exploring our patient
groups information needs as well as providing a self per-
formance check. Our audit showed that our centre does
perform well in admission and discharge stages; we need to
work on the in patient period. In order to collect the required
data, we have decided to give patients the data collection
tool on admission rather than discharge.504
Can Platelet transfusion be unnecessary?
Serpil Vieira, Diane Monroe. The London Clinic, London,
United Kingdom
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Introduction Blood transfusion continues to be an essential
part of modern practise, but it is not without risk. During the
last decade there has been an increased interest across the
United Kingdom (UK) and Europe in collecting data on the
hazards of transfusion of blood components. Therefore
avoiding unnecessary transfusion is accepted as one way ofreducing the risk, which is associated with blood transfusion.
In our stem cell transplant unit we audited platelet trans-
fusion (PT).
Methods, Intervention, & Analysis: Method The audit was
carried out prospectively and retrospectively. The data was
validated and cross checked retrospectively, all inpatient
episodes were recorded on a monthly basis. The audit was
carried out over a 29 month period from May 2010 until the
end of September 2012. The duration was divided in three
periods in order to compare the outcome with our initial
audit.
Period I: 01/05/10- 31/10/10
Period II: 01/11/10- 30/09/11
Period III: 01/10/11- 30/09/12
Findings & Interpretation: Our unit policy is to keep the
platelet count at circa 10X109/L for uncomplicated inpatients
and at circa 20 x 109/L for complicated patients and out-
patients. We also aimed to keep platelet above 50 x 109/L if
patient is receiving anticoagulant or bleeding for various
reasons. In the comparison of the three periods, there was a
dramatic improvement in terms of reducing the unnecessary
platelet transfusion. As shown on Table 1, in period I 36% of
the transfusion occurred when plt> 31 x 109/L, where as on
period III, this ﬁgure dropped to 13.95. The reasons for un-
usual transfusion were bleeding, prior to invasive procedure
and anticoagulant use. As the ﬁgures are shown there was a
dramatic change in the period II and III compared with
period I regarding unnecessary platelet transfusion. It is also
highlighted the recent change in anticoagulant use due to
new VTE prophylaxis has caused in the numbers of platelet
transfusion when plt > 31X x 109/L. Even though there was
an increase due to VTE policy, the ﬁgures were still lower
than previous periods.
Discussion & Implications: Our organisation recognises the
importance of risk associated in unnecessary blood compo-
nent transfusion. Our audit has shown interesting ﬁgures.
The duration of audit was divided in three different periods
and outcomes compared. Between these three periods there
were dramatic changes as Table II shows. Our ﬁgures drop-
ped rapidly from 45.5% to 16.6% in platelet transfusion when
the platelet count was higher than 31 x109/L. There were
various reasons to transfuse platelets even though the count
was reasonable for the haematology patient group such as:
bleeding, prior to invasive procedure and anticoagulant use.505
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Blood transfusion continues to be an essential part of modern
practise but it is not without risk. During the last decade there
has been an increased interest across the United Kingdom
(UK) and Europe for collecting data on the hazards of trans-
fusion of blood components. Therefore avoiding unnecessary
transfusion is accepted as oneway of reducing the risk, which
is associated with blood transfusion. In our stem cell trans-
plant unit we have audited red cell transfusions. Our unit
policy is to keep the haemoglobin level above 8g/dL, this may
change from time to time and depends on the patient’s
clinical condition.
Methods, Intervention, & Analysis: The audit was carried
out prospectively and retrospectively. The datawas validated
and cross checked retrospectively, all inpatient data was
recorded on amonthly basis. The audit was carried out over a
period of 29 months from May 2010 until end of September
